EP3558215A1 - Composition having -crystalline phase - Google Patents

Composition having -crystalline phase

Info

Publication number
EP3558215A1
EP3558215A1 EP16924222.9A EP16924222A EP3558215A1 EP 3558215 A1 EP3558215 A1 EP 3558215A1 EP 16924222 A EP16924222 A EP 16924222A EP 3558215 A1 EP3558215 A1 EP 3558215A1
Authority
EP
European Patent Office
Prior art keywords
composition
taurate
sodium
weight
alcohol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP16924222.9A
Other languages
German (de)
French (fr)
Other versions
EP3558215B1 (en
EP3558215A4 (en
EP3558215C0 (en
Inventor
Ji SONG
Xiaomin WENG
Haiquan LU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LU, HAIQUAN
SONG, JI
WENG, XIAOMIN
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of EP3558215A1 publication Critical patent/EP3558215A1/en
Publication of EP3558215A4 publication Critical patent/EP3558215A4/en
Application granted granted Critical
Publication of EP3558215B1 publication Critical patent/EP3558215B1/en
Publication of EP3558215C0 publication Critical patent/EP3558215C0/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/342Alcohols having more than seven atoms in an unbroken chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate

Definitions

  • the present invention relates to a composition having an ⁇ -crystalline phase. It relates more particularly to a composition having an ⁇ -crystalline phase formed by oily globules provided with a lamellar crystal coating and dispersed in an aqueous phase.
  • the present invention also relates to a process for caring for and/or making up keratin materials and in particular the skin.
  • compositions with lamellar structures such as ⁇ -gel or liquid crystal structures
  • lamellar structures such as ⁇ -gel or liquid crystal structures
  • the cosmetic compositions are capable of providing to the skin a good retention of water, and therefore a long-lasting moistness.
  • surfactants were used for stabilizing the ⁇ -gel structure and providing to the skin a water retention effect.
  • US 2014/0100276 discloses an emulsion composition which allows water to remain in the skin for a long period of time, wherein the emulsion presents a lamellar structure, which is, in particular in form of ⁇ -gel.
  • Mentions can also be made to the known products on the market, using combinations of surfactants to formulate creams with liquid crystal structure.
  • the optical effect of a cosmetic product is an important aspect. Consumers are now more and more in favour of cosmetic compositions, especially compositions caring for the skin, with optical effect in order to make the skin beautiful, or to cover the imperfections on the skin. In particular, consumers are always in search of a cosmetic product with a haze (blurring) effect.
  • compositions for caring for /making up keratin materials with haze (blurring) effect while avoid dry squeaky or artificial slippery sensation wherein the composition is stable, in particular under high temperatures, such as 45 °C.
  • composition having an ⁇ -crystalline phase with a combination of oil (s) , specific solid fatty alcohol (s) , and specific anionic surfactant (s) .
  • composition having an ⁇ -crystalline phase comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
  • the weight ratio of the solid fatty alcohol (b) /the anionic surfactant (c) ranges from 1 to 40
  • ⁇ -crystalline phase having a surface area moment mean diameter D [3, 2] ranging from 1 ⁇ m to 35 ⁇ m.
  • the present invention also relates to a process for caring for/making up keratin materials, in particular the skin, comprising the application to the keratin materials of the composition according to the present invention.
  • the present invention also relates to the use of the composition according to the present invention for caring for keratin materials, in particular the skin.
  • the diameter D [3, 2] of the ⁇ -crystalline phase according to the present invention is a parameter for referring to the surface weighted mean, also known as the surface area moment mean diameter or Sauter mean.
  • the diameter of the ⁇ -crystalline phase may be measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern.
  • composition of the present invention has a blurring effect upon application.
  • the blurring effect is characterized by instrumental measurement of haze of the composition according to the present invention.
  • the haze value is measured by the machine Haze-gard Plus sold by the company BYK.
  • the measurement is conducted by preparing a film the composition of the present invention with a thickness of 25 ⁇ m using the machine Elcometer 4340 Automatic Film Applicator on a transparent film (BYK Byko-charts clear polyester-2mil #2871) .
  • keratin materials we intend to mean human keratin materials and more specifically the skin.
  • the composition comprises at least one oil.
  • oils refers to any fatty body in liquid form at room temperature (20-25°C) and atmospheric pressure. These oils may be of animal, plant, mineral or synthetic origin.
  • the oils may be volatile or non-volatile.
  • volatile oil refers to any non-aqueous medium capable of evaporating from the skin or lips, in less than one hour, at room temperature (20-25°C) and atmospheric pressure (760 mmHg) .
  • the volatile oil is a volatile cosmetic oil, liquid at room temperature. More specifically, a volatile oil has an evaporation rate of between 0.01 and 200mg/cm 2 /min, inclusive.
  • non-volatile oil is intended to mean an oil remaining on the skin or keratin fiber at ambient temperature and atmospheric pressure.
  • a non-volatile oil has an evaporation rate strictly below 0.01 mg/cm 2 /min.
  • oils that are suitable for the present invention may be hydrocarbon-based, silicone-based or fluorine-based.
  • silicon oil refers to an oil including at least one silicon atom, and in particular at least on Si-O group.
  • fluorine oil refers to an oil including at least one fluorine atom.
  • hydrocarbon-based oil refers to an oil containing primarily hydrogen and carbon atoms.
  • the oils may optionally include oxygen, nitrogen, sulfur and/or phosphorus atoms, for example, in the form of hydroxyl or acid radicals.
  • the composition of the present invention comprises hydrocarbon oil (s) .
  • the volatile oils may be chosen from hydrocarbon oils having 8 to 16 carbon atoms, and in particular branched C 8 -C 16 alkanes (also called isoparaffins or isoalkanes) , such as isododecane (also called 2, 2, 4, 4, 6-pentamethylheptane) , isodecane, isohexadecane, and, for example, the oils sold under the trade names or
  • linear C 9 -C 17 alkanes such as dodecane (C 12 ) and tetradecane (C 14 ) , sold respectively under the names 12-97 and 14-97 (Sasol)
  • alkanes obtained according to the method described in the international application WO 2007/068371 A1 such as the undecane (C 11 ) and tridecane (C 13 ) mixture sold under the name UT (Cognis) .
  • the non-volatile oils may, in particular, be chosen from among the non-volatile hydrocarbon oils.
  • oils of plant origin such as phytostearyl esters, for instance phytostearyl oleate, phytostearyl isostearate and lauroyl/octyldodecyl/phytostearyl glutamate (AJINOMOTO, ELDEW PS203) , diesters such as diisopropyl sebacate, triglycerides constituted of fatty acid esters of glycerol, in particular in which the fatty acids may have chain lengths ranging from C 4 to C 36 , and in particular from C 18 to C 36 , it being possible for these oils to be linear or branched, and saturated or unsaturated; these oils may in particular be heptanoic or octanoic triglycerides, shea oil, alfalfa oil, poppy seed oil, pumpkin oil, millet oil, barley oil, quinoa oil, rye oil, candlenut oil, passionflower oil, shea butter, aloe oil, sweet almond oil,
  • John's Wort oil monoi oil, hazelnut oil, apricot kernel oil, nut oil, olive oil, evening primrose oil, palm oil, blackcurrant seed oil, kiwi seed oil, grape seed oil, pistachio oil, pumpkin oil, winter squash oil, quinoa oil, musk rose oil, sesame oil, soya oil, sunflower oil, castor oil and watermelon oil, and mixtures thereof, or alternatively caprylic/capric acid triglycerides, for instance those sold by the STEARINERIES DUBOIS company or those sold under the names MIGLYOL and by the DYNAMIT NOBEL company,
  • oils of formula R 1 COOR 2 in which R 1 represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms, and R 2 represents a hydrocarbon-based chain, in particular a branched chain, containing from 1 to 40 carbon atoms provided that R 1 or R 2 is greater than or equal to 10.
  • the esters may in particular be selected from esters of fatty acid and of alcohol, for instance: cetostearyl octanoate, isopropyl alcohol esters, such as isopropyl myristate, isopropyl palmitate, ethyl palmitate, 2-ethylhexyl palmitate, isopropyl stearate or isostearate, isostearyl isostearate, octyl stearate, hydroxylated esters, for instance isostearyl lactacte, octyl hydroxystearate, diisopropyl adipate, heptanoates, and especially isostearyl heptanoate, alcohol or polyalcohol octanoates, decanoates or ricinoleates, for instance propylene glycol dioctanoate, cetyl octanoate, tridecyl octanoate, 2-ethylhe
  • - fatty alcohols that are liquid at ambient temperature, with a branched and/or unsaturated carbon chain having from 12 to 26 carbon atoms, for instance 2-octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol and 2-undecylpentadecanol,
  • higher fatty acids such as oleic acid, linoleic acid or linolenic acid, and mixtures thereof, and,
  • R 1 and R 2 each represents a linear or branched hydrocarbon chain comprising from 3 to 30 carbon atoms.
  • R 1 and R 2 which are identical, represent a linear hydrocarbon chain comprising from 3 to 8 carbon atoms.
  • dialkyl carbonate is dicaprylyl carbonate.
  • the carbonate is caprylyl carbonate.
  • the two alkyl chains possibly being identical such as the dicaprylyl carbonate sold under the name CETIOL by COGNIS.
  • oils of higher molar mass having in particular a molar mass ranging from approximately 400 to approximately 10,000 g/mol, in particular from approximately 650 to approximately 10,000 g/mol, in particular from approximately 750 to approximately 7500 g/mol, and more particularly ranging from approximately 1000 to approximately 5000 g/mol.
  • oils of higher molar mass that can be used in the present invention, mention may in particular be made of the oils selected from:
  • esters of C 24 -C 28 branched fatty acids or fatty alcohols
  • composition of the present invention comprises, as oil, dicaprylyl carbonate.
  • the at least one oil (a) is present in an amount ranging from 0.1%to 15%by weight, preferably ranging from 1%to 10%by weight, relative to the total weight of the composition.
  • composition of the present invention comprises greater than or equal to 3%by weight of at least one solid fatty alcohol, relative to the total weight of the composition.
  • fatty alcohol means a long-chain aliphatic alcohol comprising from 8 to 40 carbon atoms, preferably from 12 to 34 or even from 12 to 30 carbon atoms, and comprising at least one hydroxyl group OH. These fatty alcohols are neither oxyalkylenated nor glycerolated.
  • the “solid fatty alcohols” are solid at room temperature (25°C) and at atmospheric pressure (780 mmHg or 1 atm. ) ; they are water-insoluble, i.e. they have a solubility in water of less than 1%by mass and preferably less than 0.5%by weight.
  • the solid fatty alcohols are of structure R—OH with R denoting a saturated or unsaturated, linear alkyl group, optionally substituted with one or more hydroxyl groups, comprising from 14 to 30 carbon atoms.
  • the solid fatty alcohols used in the present invention are selected from fatty alcohols having from 14 to 30 carbon atoms.
  • Mentions may be made of, as solid fatty alcohols, myristyl alcohol (1-tetradecanol) , cetyl alcohol (1-hexadecanol) , palmitoleyl alcohol (cis-9-hexadecen-1-ol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , erucyl alcohol (cis-13-docosen-1-ol) , lignoceryl alcohol (1-tetracosanol) , ceryl alcohol (1-hexacosanol) , myricyl alcohol, or melissyl alcohol (1-triacontanol) .
  • the solid fatty alcohol is selected from alcohols having from 14 to 22 carbon atoms, such as cetyl alcohol (1-hexadecanol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , or a mixture thereof.
  • the solid fatty alcohol are selected from cetyl alcohol (1-hexadecanol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , or a mixture thereof.
  • the fatty alcohols may be mixtures, which mean, for example, that several species may coexist in a commercial product, especially of different chain lengths, in the form of a mixture.
  • Mentions of such mixture of fatty alcohols may be made of cetearyl alcohol sold under the name Lanette O Or by BASF, wherein containing predominantly a mixture of cetyl alcohol and stearyl alcohol.
  • the solid fatty alcohol (b) is present in an amount greater than or equal to 3%by weight, preferably from 3%to 15%by weight, more preferably from 3%to 10%by weight, relative to the total weight of the composition.
  • composition of the present invention comprises at least one anionic surfactant of fatty acid amide sulfonate salt.
  • the anionic surfactant is at least one amino acid surfactant of the following formula (II) :
  • R 1 is a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms atoms,
  • R 2 is H or a methyl
  • R 3 is H, COO - M + , CH 2 COO-M or COOH,
  • n 0 to 2
  • X is COO - or SO 3 - and
  • M is independent from each other H, sodium or potassium and a sorbitan surfactant.
  • anionic surfactants are those described in EP2335681.
  • amino acid surfactant types are taurate, glutamate, alanin or alaninate, sarcosinate, aspartate surfactants, and mixtures thereof.
  • taurate, glutamate and sarcosinate surfactants and mixtures thereof. More preferred are taurates and glutamates and most preferred is glutamate type surfactants.
  • Suitable taurate surfactants are according to the general formula (III)
  • R 1 is preferably a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms, and more preferably 9 to 13 carbon atoms,
  • R 2 is H or methyl
  • M is H, sodium or potassium.
  • Suitable examples are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium caproyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl myristoyl taurate, sodium methyl oleoyl taurate, sodium methyl palmitoyl taurate, and sodium methyl stearoyl taurate and mixtures thereof.
  • compositions of the present invention can also comprise mixture of several type of amino acid surfactants such as mixture of glutamate and taurate surfactants, or mixture of taurate, glutamate and sarcosinate surfactants etc.
  • amino acid surfactant especially those surfactants are meant derived from taurate, glucamate, alanin or alaninate, sarcosinate and aspartate.
  • the at least one anionic surfactant is a member selected from the group consisting of an isethionate, a taurate, a sarcosinate, a sulfosuccinate, a sulfoacetate, a glycinate, a glutamate and a carboxylate, wherein the at least one anionic surfactant has an alkyl chain from C 8 to C 20 , and a solubilizing counter cation selected from sodium, potassium and ammonium.
  • the at least one anionic surfactant is a taurate, the taurate having an alkyl chain from C 8 to C 20 , and a solubilizing counter cation selected from sodium, potassium and ammonium.
  • the at least one anionic surfactant is a member selected from the group consisting of sodium lauryl methyl isethionate, sodium methyl oleoyl taurate, sodium N-myristoyl-N-methyltaurate, sodium coconut oil fatty acid methyltaurate, and sodium laurylmethyltaurate.
  • the anionic surfactant is sodium methyl stearoyl taurate.
  • the anionic surfactant (c) is present in an amount ranging from 0.05%to 3%by weight, and preferably from 0.1%to 1%by weight, relative to the total weight of the composition.
  • the weight ratio of the at least one solid fatty alcohol (b) and at least one anionic surfactant (c) is 1 to 40, preferably from 5 to 35, and more preferably from 15 to 35.
  • the composition of the present invention possesses a desired optical/haze/blurring effect.
  • the haze value of the composition is greater than or equal to 30, more preferably greater than or equal to 35.
  • the haze value is measured by using Haze meter.
  • the haze value is measured by the machine Haze-gard Plus sold by the company BYK.
  • the measurement is conducted by preparing a film the composition of the present invention with a thickness of 25 ⁇ m using the machine Elcometer 4340 Automatic Film Applicator on a transparent film (BYK Byko-charts clear polyester-2mil #2871) . The measurement is repeated 5 times to obtain an average haze value.
  • the composition according to the present invention has haze (blurring) effect without commonly used raw material with high haze (blurring) effect, such as whitening charges or silicon lassoers, thus dry squeaky or artificial slippery sensation is avoided.
  • composition of the present invention comprises an ⁇ -crystalline phase, or also called as ⁇ -gel.
  • ⁇ -crystalline phase, or ⁇ -gel has a hydrate-type crystal structure, which is a lamellar structure. Such structure enables the composition of the present invention a satisfied hydration effect to the keratin materials, in particular the skin.
  • the present invention makes it possible to have available particularly stable emulsions having small droplets of oily phase coated with a monolamellar layer and/or with an oligolamellar layer which is extremely thin.
  • Oligolamellar layer is understood to mean a layer comprising from 2 to 5 lipid lamellar (lipid lamellar is understood to mean a membrane of lipid bilayer type as described in the field of liposomes, for example) .
  • the ⁇ -crystalline phase of the composition has a diameter D [3, 2] ranging from 1 ⁇ m to 35 ⁇ m.
  • the diameter of the ⁇ -crystalline phase of the composition ranges from 3 ⁇ m to 25 ⁇ m.
  • the diameter D [3, 2] according to the present invention may be measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern.
  • the diameter D [3, 2] is measured by the following protocol:
  • composition according to the present invention diluting the composition according to the present invention to 10%in water.
  • the dilution process can be adjusted according to the viscosity of the composition to be measured by a man skilled in the art;
  • composition of the present invention comprises at least one continuous aqueous phase.
  • the aqueous phase includes water, as the case may be, in a mixture with water-soluble additives and/or solvents.
  • the aqueous phase may also comprise organic solvents miscible with water (at room temperature -25°C) such as for example monoalcohols having from 2 to 6 carbon atoms such as ethanol, isopropanol; polyols notably having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylylglycol, dipropylene glycol, diethylene glycol; glycol ethers (notably having from 3 to 16 carbon atoms) such as mono-, di-or tri-propylene glycol (C 1 -C 4 ) alkyl ethers, mono-, di-or tri-ethylene glycol (C 1 -C 4 ) alkyl ethers and mixtures thereof.
  • organic solvents miscible with water such as for example monoalcohols having from 2 to
  • the aqueous phase of the compositions of the present invention comprises a polyol notably glycerol, caprylylglycol or propylene glycol, and a monoalcohol, notably ethanol.
  • the amount of aqueous phase may range, for example, from 70%to 97%by weight, preferably from 75%to 95%by weight relative to the total weight of the composition.
  • the amount of water in the compositions according to the present invention ranges from 70%to 97%by weight, preferably from 75%to 95%by weight, relative to the total weight of the composition.
  • compositions of the present invention comprise more than 80%by weight of water relative to the total weight of the composition.
  • the aqueous phase may also contain other additives such as water-soluble active ingredients, preservatives, salts, gelling agents, additional fillers, additional water-soluble or water-dispersible polymers, water-soluble dyes, and so on.
  • additives such as water-soluble active ingredients, preservatives, salts, gelling agents, additional fillers, additional water-soluble or water-dispersible polymers, water-soluble dyes, and so on.
  • gelling agents are:
  • carboxyvinyl polymers such as the products sold under the Carbopol (INCI name: carbomer) and Pemulen (INCI name: Acrylates/C10-30 alkyl acrylate crosspolymer) names by Goodrich;
  • ⁇ acrylate/acrylonitrile copolymers such as Hypan SS201, sold by Singer;
  • ⁇ polysaccharide biopolymers such as xanthan gum, guar gum, alginates or modified or unmodified celluloses
  • ⁇ inorganic compounds such as smectites or modified or unmodified hectorites, such as the Bentone products sold by Rheox, the Laponite products sold by Southern Clay Products or the product Veegum HS sold by R. T. Vanderbilt;
  • Use is preferably made, as hydrophilic gelling agent, of optionally crosslinked polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid.
  • the gelling agent can be present in the composition in a content (in dry material) ranging for example from 0.001%to 3%by weight, preferably from 0.01%to 1%by weight, relative to the total weight of the composition.
  • a composition according to the present invention comprises at least one dispersed oily phase.
  • the oily phase has a refractive index of above 1.43, preferably above 1.50.
  • the refractive index mentioned above is a final refractive index of the oily phase.
  • the oils chosen to be present in the oily phase of the current invention shall reach the condition that the refractive index of the oil phase is of above 1.43, preferably above 1.50.
  • the composition of the present invention having an ⁇ -crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
  • composition of the present invention is prepared as follows:
  • Lab Homogenization is preferably performed with a high shear mixer, such as those manufactured by Silverson.
  • Stirring is preferably performed by VMI mixers.
  • the composition of the present invention is a cosmetic composition for caring for and/or making up keratin materials, and may be in form of lotion, toner, cream, or spray.
  • composition of the present invention is stable over time.
  • “Stable over time” is understood to mean compositions of the present invention which, after storage at all temperatures between 4°C and 45° for 2 months, do not exhibit any macroscopic change in colour, smell or viscosity, any variation in pH or any variation in microscopic appearance.
  • composition of the present invention can be used for a cosmetic process, such as a cosmetic process or method, for making up/caring for the keratin materials, such as the skin, in particular the face and the lips, by being applied to the skin, especially the face.
  • a cosmetic process such as a cosmetic process or method
  • the keratin materials such as the skin, in particular the face and the lips
  • the present invention also relates to a use of the composition according to the present invention, for making up/caring for the skin, especially for the face.
  • the present invention relates to a cosmetic process for caring for and/or making up a keratin material, comprising the application, to the keratin material, of at least one composition of the present invention, wherein the keratin material is preferably the skin, in particular the face.
  • composition according to the present invention can be used to make the skin anti-finelines during the day. And the composition according to the present invention is easy to spread and penetrate, leaving non-sticky/oily feeling.
  • compositions according to the present invention as well as comparative composition were prepared according to the concentration given in table 1.
  • Comparative composition 1 comprises less than 3%by weight of solid fatty alcohol.
  • the Invention compositions and comparative composition were prepared following the steps of:
  • phase A and phase B respectively, in a melter at the temperature of 75-80 °C with stirring at 1000 rpm /min until a homogeneous phase;
  • phase B is added to phase A, using a mixer at 2300 rpm (silverson) for 10 minutes to obtain a homogenous mixture;
  • Example 2 Evaluation of the Invention compositions and comparative composition ⁇ -crystalline phase ( ⁇ -gel) , the hydrophobic groups of a lamellar liquid crystalline phase are in a molten (liquid) state with a specific sub-lattice structure.
  • the D [3.2] , haze value, stability and cosmetic property of the compositions according to Invention and the comparative composition were evaluated.
  • the D [3.2] and haze value were evaluated following the method aforementioned.
  • compositions according to invention and the comparative composition were evaluated by leaving the compositions at 45 °C for 2 months, and observing the compositions using microscope under polarized light.
  • compositions according to Invention and Comparative composition were given to 10 consumers for application on the facial skin, respectively, and the cosmetic property, such as hydration effect on the skin was scored by the consumers.
  • compositions according to invention both have improved haze (blurring) effects, and such effects are stable over 2 months, under 45 °C.
  • compositions according to the present invention present good hydration effect upon application, comparing to the comparative composition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

A composition having an α-crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising: (a) at least one oil; (b) greater than or equal to 3%by weight of at least one solid fatty alcohol, relative to the total weight of the composition; and (c) at least one anionic surfactant of fatty acid amide sulfonate salts, wherein the weight ratio of the solid fatty alcohol (b) /the anionic surfactant (c) is from 1 to 40, wherein the α-crystalline phase having a surface area moment mean diameter D [3, 2] ranging from 1μm to 35μm.

Description

    [Title established by the ISA under Rule 37.2] Composition having  α-crystalline phase TECHNICAL FIELD
  • The present invention relates to a composition having an α-crystalline phase. It relates more particularly to a composition having an α-crystalline phase formed by oily globules provided with a lamellar crystal coating and dispersed in an aqueous phase. The present invention also relates to a process for caring for and/or making up keratin materials and in particular the skin.
  • BACKGROUND
  • In the cosmetic art it is known to formulate compositions with lamellar structures, such as α-gel or liquid crystal structures, for improving the stability of cosmetic compositions. Moreover, thanks to the lamellar structure, i.e., repeating bilayer structures, the cosmetic compositions are capable of providing to the skin a good retention of water, and therefore a long-lasting moistness. Various types of surfactants were used for stabilizing the α-gel structure and providing to the skin a water retention effect.
  • For example, US 2014/0100276 discloses an emulsion composition which allows water to remain in the skin for a long period of time, wherein the emulsion presents a lamellar structure, which is, in particular in form of α-gel.
  • Mentions can also be made to the known products on the market, using combinations of surfactants to formulate creams with liquid crystal structure.
  • On the other hand, the optical effect of a cosmetic product is an important aspect. Consumers are now more and more in favour of cosmetic compositions, especially compositions caring for the skin, with optical effect in order to make the skin beautiful, or to cover the imperfections on the skin. In particular, consumers are always in search of a cosmetic product with a haze (blurring) effect.
  • However, among all the known arts, in order to achieve some haze (blurring) effect, high haze (blurring) effect raw materials, such as whitening charges or silicone elastomers are used, which will result in dry squeaky or artificial slippery sensation.
  • Also it is difficult to solve these technical problems by simply formulating whitening charges or silicone elastomers into a lamellar structure composition, with the aim of preparing a composition for treating keratin materials and remain stable, in particular under high temperatures, such as 45 ℃.
  • Therefore there is a need to formulate a composition with a lamellar structure, and delivering a blurring effect to keratin materials, such as the skin.
  • Besides, there is a need to formulate such a composition as mentioned above, with a good skin feeling, such as water retention, moisturizing feeling.
  • There is a need to formulate a composition for caring for /making up keratin materials with haze (blurring) effect while avoid dry squeaky or artificial slippery sensation, wherein the composition is stable, in particular under high temperatures, such as 45 ℃.
  • SUMMARY OF THE INVENTION
  • The applicant found that such a need can be met by formulating a composition having an α-crystalline phase, with a combination of oil (s) , specific solid fatty alcohol (s) , and specific anionic surfactant (s) .
  • More specifically, the present invention relates to a composition having an α-crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
  • (a) at least one oil;
  • (b) greater than or equal to 3%by weight of at least one solid fatty alcohol relative to the total weight of the composition; and
  • (c) at least one anionic surfactant of fatty acid amide sulfonate salts,
  • wherein the weight ratio of the solid fatty alcohol (b) /the anionic surfactant (c) ranges from 1 to 40,
  • wherein the α-crystalline phase having a surface area moment mean diameter D [3, 2] ranging from 1μm to 35μm.
  • The present invention also relates to a process for caring for/making up keratin materials, in particular the skin, comprising the application to the keratin materials of the composition according to the present invention.
  • The present invention also relates to the use of the composition according to the present invention for caring for keratin materials, in particular the skin.
  • The diameter D [3, 2] of the α-crystalline phase according to the present invention is a parameter for referring to the surface weighted mean, also known as the surface area moment mean diameter or Sauter mean. The diameter of the α-crystalline phase may be  measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern.
  • The composition of the present invention has a blurring effect upon application.
  • The blurring effect is characterized by instrumental measurement of haze of the composition according to the present invention.
  • In particular, the haze value is measured by the machine Haze-gard Plus sold by the company BYK.
  • The measurement is conducted by preparing a film the composition of the present invention with a thickness of 25μm using the machine Elcometer 4340 Automatic Film Applicator on a transparent film (BYK Byko-charts clear polyester-2mil #2871) .
  • By “keratin materials” we intend to mean human keratin materials and more specifically the skin.
  • Other subjects and characteristics, aspects and advantages of the present invention will emerge even more clearly on reading the description and the examples that follows. In that which follows and unless otherwise indicated, the limits of a range of values are included within this range, in particular in the expressions "of between" and "ranging from ... to ... " .
  • Moreover, the expression "at least one" used in the present description is equivalent to the expression "one or more" .
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • (a) oil
  • According to the present invention, the composition comprises at least one oil.
  • The term “oil” refers to any fatty body in liquid form at room temperature (20-25℃) and atmospheric pressure. These oils may be of animal, plant, mineral or synthetic origin.
  • The oils may be volatile or non-volatile.
  • The term "volatile oil" refers to any non-aqueous medium capable of evaporating from the skin or lips, in less than one hour, at room temperature (20-25℃) and atmospheric pressure (760 mmHg) .
  • More specifically, the volatile oil is a volatile cosmetic oil, liquid at room temperature. More specifically, a volatile oil has an evaporation rate of between 0.01 and 200mg/cm2/min, inclusive.
  • The term "non-volatile oil" is intended to mean an oil remaining on the skin or keratin fiber at ambient temperature and atmospheric pressure.
  • More specifically, a non-volatile oil has an evaporation rate strictly below 0.01 mg/cm2/min.
  • To measure this evaporation rate, 15g of oil or a mixture of oils to be tested are introduced into a crystallizer, 7cm in diameter, placed on a scale located in a large 0.3m3 chamber temperature-controlled at a temperature of 25℃, and humidity-controlled with a relative humidity of 50%. The liquid is left to evaporate freely, without stirring, by providing ventilation with a fan (PAPST-MOTOREN, reference 8550 N, rotating at 2700 rpm) positioned vertically above the crystallizer containing the solvent, with the blades directed toward the crystallizer and at a distance of 20cm from the base of the crystallizer. The mass of oil remaining in the crystallizer is measured at regular intervals. The evaporation rates are expressed in mg of oil evaporated per surface area unit (cm2) and per time unit (minute) .
  • The oils that are suitable for the present invention may be hydrocarbon-based, silicone-based or fluorine-based.
  • According to the present invention, the term "silicone oil" refers to an oil including at least one silicon atom, and in particular at least on Si-O group.
  • The term "fluorine oil" refers to an oil including at least one fluorine atom.
  • The term "hydrocarbon-based oil" refers to an oil containing primarily hydrogen and carbon atoms.
  • The oils may optionally include oxygen, nitrogen, sulfur and/or phosphorus atoms, for example, in the form of hydroxyl or acid radicals.
  • More preferably, the composition of the present invention comprises hydrocarbon oil (s) . Specifically, the volatile oils may be chosen from hydrocarbon oils having 8 to 16 carbon atoms, and in particular branched C8-C16 alkanes (also called isoparaffins or isoalkanes) , such as isododecane (also called 2, 2, 4, 4, 6-pentamethylheptane) , isodecane, isohexadecane, and, for example, the oils sold under the trade names  or 
  • It is also possible to cite, as a hydrocarbon volatile oil, linear C9-C17 alkanes, such as dodecane (C12) and tetradecane (C14) , sold respectively under the names  12-97 and  14-97 (Sasol) , and, as alkanes obtained according to the method described in the international application WO 2007/068371 A1, such as the undecane (C11) and tridecane (C13) mixture sold under the name  UT (Cognis) .
  • The non-volatile oils may, in particular, be chosen from among the non-volatile hydrocarbon oils.
  • It is possible to cite, as a non-volatile hydrocarbon oil:
  • - hydrocarbon oils of animal origin, such as perhydrosqualene,
  • - hydrocarbon oils of plant origin, such as phytostearyl esters, for instance phytostearyl oleate, phytostearyl isostearate and lauroyl/octyldodecyl/phytostearyl glutamate (AJINOMOTO, ELDEW PS203) , diesters such as diisopropyl sebacate, triglycerides constituted of fatty acid esters of glycerol, in particular in which the fatty acids may have chain lengths ranging from C4 to C36, and in particular from C18 to C36, it being possible for these oils to be linear or branched, and saturated or unsaturated; these oils may in particular be heptanoic or octanoic triglycerides, shea oil, alfalfa oil, poppy seed oil, pumpkin oil, millet oil, barley oil, quinoa oil, rye oil, candlenut oil, passionflower oil, shea butter, aloe oil, sweet almond oil, peach kernel oil, groundnut oil, argan oil, avocado oil, baobab oil, barrage oil, broccoli oil, calendula oil, camelina oil, canola oil, carrot oil, safflower oil, hemp oil, rapeseed oil, cotton seed oil, coconut oil, marrow seed oil, wheat germ oil, jojoba oil, lily oil, macadamia oil, corn oil, meadowfoam oil, St. John's Wort oil, monoi oil, hazelnut oil, apricot kernel oil, nut oil, olive oil, evening primrose oil, palm oil, blackcurrant seed oil, kiwi seed oil, grape seed oil, pistachio oil, pumpkin oil, winter squash oil, quinoa oil, musk rose oil, sesame oil, soya oil, sunflower oil, castor oil and watermelon oil, and mixtures thereof, or alternatively caprylic/capric acid triglycerides, for instance those sold by the STEARINERIES DUBOIS company or those sold under the names MIGLYOL  and  by the DYNAMIT NOBEL company,
  • - linear or branched hydrocarbons of mineral or synthetic origin, such as liquid paraffins and derivatives thereof, petroleum jelly, polydecenes, polybutenes, hydrogenated polyisobutene such as Parleam, squalane;
  • - synthetic ethers having from 10 to 40 carbon atoms;
  • - synthetic esters, for instance oils of formula R1COOR2, in which R1 represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms, and R2 represents a hydrocarbon-based chain, in particular a branched chain, containing from 1 to 40 carbon atoms provided that R1 or R2 is greater than or equal to 10. The esters may in particular be selected from esters of fatty acid and of alcohol, for instance: cetostearyl octanoate, isopropyl alcohol esters, such as isopropyl myristate, isopropyl palmitate, ethyl palmitate, 2-ethylhexyl palmitate, isopropyl stearate or isostearate, isostearyl isostearate, octyl stearate, hydroxylated esters, for instance isostearyl lactacte, octyl hydroxystearate, diisopropyl adipate, heptanoates, and especially isostearyl heptanoate, alcohol or polyalcohol octanoates, decanoates or ricinoleates, for instance propylene glycol dioctanoate, cetyl octanoate, tridecyl octanoate, 2-ethylhexyl 4-diheptanoate and palmitate, alkyl benzoate, polyethylene glycol diheptanoate, propylene glycol 2-diethylhexanoate, and mixtures thereof, C12-C15 alkyl benzoates, hexyl laurate, neopentanoic acid esters, for instance isodecyl neopentanoate, isotridecyl neopentanoate,  isostearyl neopentanoate, or octyldodecyl neopentanoate, isononanoic acid esters, for instance isononyl isononanoate, isotridecyl isononanoate and octyl isononanoate, hydroxylated esters such as isostearyl lactate and diisostearyl malate;
  • - polyol esters and pentaerythritol esters, for instance dipentaerythrityl tetrahydroxystearate/tetraisostearate,
  • - esters of diol dimers and diacid dimers, such as Lusplan  and Lusplan  sold by the NIPPON FINE CHEMICAL company and described in the application US 2004-175338,
  • - copolymers of a diol dimer and of a diacid dimer and esters thereof, such as copolymers of dilinoleyl diol dimers/dilinoleic dimers and esters thereof, for instance Plandool-G,
  • - copolymers of polyols and of diacid dimers, and esters thereof, such as Hailuscent ISDA, or the copolymer of dilinoleic acid/butanediol,
  • - fatty alcohols that are liquid at ambient temperature, with a branched and/or unsaturated carbon chain having from 12 to 26 carbon atoms, for instance 2-octyldodecanol, isostearyl alcohol, oleyl alcohol, 2-hexyldecanol, 2-butyloctanol and 2-undecylpentadecanol,
  • - C12-C22, higher fatty acids, such as oleic acid, linoleic acid or linolenic acid, and mixtures thereof, and,
  • - dialkyl carbonates of the following formula (I) :
  • wherein R1 and R2, identical or different, each represents a linear or branched hydrocarbon chain comprising from 3 to 30 carbon atoms.
  • Preferably, according to an embodiment, in formula (I) , R1 and R2, which are identical, represent a linear hydrocarbon chain comprising from 3 to 8 carbon atoms.
  • More preferably, the dialkyl carbonate is dicaprylyl carbonate.
  • In one embodiment, the carbonate is caprylyl carbonate. the two alkyl chains possibly being identical such as the dicaprylyl carbonate sold under the name CETIOL  by COGNIS.
  • - oils of higher molar mass having in particular a molar mass ranging from approximately 400 to approximately 10,000 g/mol, in particular from approximately 650 to approximately 10,000 g/mol, in particular from approximately 750 to approximately 7500 g/mol, and more particularly ranging from approximately 1000 to approximately 5000  g/mol. As oils of higher molar mass that can be used in the present invention, mention may in particular be made of the oils selected from:
  • ● lipophilic polymers,
  • ● linear fatty acid esters having a total carbon number ranging from 35 to 70,
  • ● hydroxylated esters,
  • ● aromatic esters,
  • ● esters of C24-C28 branched fatty acids or fatty alcohols,
  • ● oils of plant origin,
  • ● and mixtures thereof; and
  • - mixtures thereof.
  • In one embodiment, the composition of the present invention comprises, as oil, dicaprylyl carbonate.
  • According to a preferred embodiment, the at least one oil (a) is present in an amount ranging from 0.1%to 15%by weight, preferably ranging from 1%to 10%by weight, relative to the total weight of the composition.
  • (b) Solid fatty alcohol
  • The composition of the present invention comprises greater than or equal to 3%by weight of at least one solid fatty alcohol, relative to the total weight of the composition.
  • The term “fatty alcohol” means a long-chain aliphatic alcohol comprising from 8 to 40 carbon atoms, preferably from 12 to 34 or even from 12 to 30 carbon atoms, and comprising at least one hydroxyl group OH. These fatty alcohols are neither oxyalkylenated nor glycerolated.
  • The “solid fatty alcohols” are solid at room temperature (25℃) and at atmospheric pressure (780 mmHg or 1 atm. ) ; they are water-insoluble, i.e. they have a solubility in water of less than 1%by mass and preferably less than 0.5%by weight.
  • Preferably, the solid fatty alcohols are of structure R—OH with R denoting a saturated or unsaturated, linear alkyl group, optionally substituted with one or more hydroxyl groups, comprising from 14 to 30 carbon atoms.
  • Preferably, the solid fatty alcohols used in the present invention are selected from fatty alcohols having from 14 to 30 carbon atoms.
  • Mentions may be made of, as solid fatty alcohols, myristyl alcohol (1-tetradecanol) , cetyl alcohol (1-hexadecanol) , palmitoleyl alcohol (cis-9-hexadecen-1-ol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , erucyl  alcohol (cis-13-docosen-1-ol) , lignoceryl alcohol (1-tetracosanol) , ceryl alcohol (1-hexacosanol) , myricyl alcohol, or melissyl alcohol (1-triacontanol) .
  • More preferably, according to the present invention, the solid fatty alcohol is selected from alcohols having from 14 to 22 carbon atoms, such as cetyl alcohol (1-hexadecanol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , or a mixture thereof.
  • More particularly, the solid fatty alcohol are selected from cetyl alcohol (1-hexadecanol) , stearyl alcohol (1-octadecanol) , arachidyl alcohol (1-eicosanol) , behenyl alcohol (1-docosanol) , or a mixture thereof.
  • The fatty alcohols may be mixtures, which mean, for example, that several species may coexist in a commercial product, especially of different chain lengths, in the form of a mixture.
  • Mentions of such mixture of fatty alcohols may be made of cetearyl alcohol sold under the name Lanette O Or by BASF, wherein containing predominantly a mixture of cetyl alcohol and stearyl alcohol.
  • According to one embodiment, the solid fatty alcohol (b) is present in an amount greater than or equal to 3%by weight, preferably from 3%to 15%by weight, more preferably from 3%to 10%by weight, relative to the total weight of the composition.
  • (c) Anionic surfactant
  • The composition of the present invention comprises at least one anionic surfactant of fatty acid amide sulfonate salt.
  • In one embodiment, the anionic surfactant is at least one amino acid surfactant of the following formula (II) :
  • wherein:
  • R1 is a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms atoms,
  • R2 is H or a methyl,
  • R3 is H, COO-M+, CH2COO-M or COOH,
  • n is 0 to 2,
  • X is COO-or SO3 -and
  • M is independent from each other H, sodium or potassium and a sorbitan surfactant.
  • Such anionic surfactants are those described in EP2335681.
  • Suitably amino acid surfactant types are taurate, glutamate, alanin or alaninate, sarcosinate, aspartate surfactants, and mixtures thereof.
  • Preferred are taurate, glutamate and sarcosinate surfactants and mixtures thereof. More preferred are taurates and glutamates and most preferred is glutamate type surfactants.
  • Suitable taurate surfactants are according to the general formula (III)
  • wherein
  • R1 is preferably a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms, and more preferably 9 to 13 carbon atoms,
  • R2 is H or methyl,
  • and M is H, sodium or potassium.
  • Suitable examples are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium caproyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl myristoyl taurate, sodium methyl oleoyl taurate, sodium methyl palmitoyl taurate, and sodium methyl stearoyl taurate and mixtures thereof. Preferred are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium caproyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate and sodium methyl lauroyl taurate and mixtures thereof. More preferred are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate and sodium methyl lauroyl taurate and mixtures thereof.
  • It should be noted that compositions of the present invention can also comprise mixture of several type of amino acid surfactants such as mixture of glutamate and taurate surfactants, or mixture of taurate, glutamate and sarcosinate surfactants etc.
  • With the term amino acid surfactant especially those surfactants are meant derived from taurate, glucamate, alanin or alaninate, sarcosinate and aspartate.
  • According to an embodiment of the present invention, the at least one anionic surfactant is a member selected from the group consisting of an isethionate, a taurate, a sarcosinate, a sulfosuccinate, a sulfoacetate, a glycinate, a glutamate and a carboxylate, wherein the at least one anionic surfactant has an alkyl chain from C8 to C20, and a solubilizing counter cation selected from sodium, potassium and ammonium.
  • According to an embodiment of the present invention, the at least one anionic surfactant is a taurate, the taurate having an alkyl chain from C8 to C20, and a solubilizing counter cation selected from sodium, potassium and ammonium.
  • According to an embodiment of the present invention, the at least one anionic surfactant is a member selected from the group consisting of sodium lauryl methyl isethionate, sodium methyl oleoyl taurate, sodium N-myristoyl-N-methyltaurate, sodium coconut oil fatty acid methyltaurate, and sodium laurylmethyltaurate.
  • According to an embodiment of the present invention, the anionic surfactant is sodium methyl stearoyl taurate.
  • According to an embodiment, the anionic surfactant (c) is present in an amount ranging from 0.05%to 3%by weight, and preferably from 0.1%to 1%by weight, relative to the total weight of the composition.
  • For the purpose of the present invention, the weight ratio of the at least one solid fatty alcohol (b) and at least one anionic surfactant (c) is 1 to 40, preferably from 5 to 35, and more preferably from 15 to 35.
  • The inventors found that, thanks to the specific weight ratio of each component as described above, the composition of the present invention possesses a desired optical/haze/blurring effect. The haze value of the composition is greater than or equal to 30, more preferably greater than or equal to 35.
  • The haze value is measured by using Haze meter. In particular, the haze value is measured by the machine Haze-gard Plus sold by the company BYK.
  • The measurement is conducted by preparing a film the composition of the present invention with a thickness of 25μm using the machine Elcometer 4340 Automatic Film Applicator on a transparent film (BYK Byko-charts clear polyester-2mil #2871) . The measurement is repeated 5 times to obtain an average haze value.
  • According to a preferred embodiment, the composition according to the present invention has haze (blurring) effect without commonly used raw material with high haze (blurring) effect, such as whitening charges or silicon lassoers, thus dry squeaky or artificial slippery sensation is avoided.
  • α-crystalline phase
  • The composition of the present invention comprises an α-crystalline phase, or also called as α-gel.
  • α-crystalline phase, or α-gel, has a hydrate-type crystal structure, which is a lamellar structure. Such structure enables the composition of the present invention a satisfied hydration effect to the keratin materials, in particular the skin.
  • The present invention makes it possible to have available particularly stable emulsions having small droplets of oily phase coated with a monolamellar layer and/or with an oligolamellar layer which is extremely thin.
  • Oligolamellar layer is understood to mean a layer comprising from 2 to 5 lipid lamellar (lipid lamellar is understood to mean a membrane of lipid bilayer type as described in the field of liposomes, for example) .
  • Diameter D [3, 2] of the α-crystalline phase according to the present invention
  • For the purpose of the present invention, the α-crystalline phase of the composition has a diameter D [3, 2] ranging from 1μm to 35 μm. Preferably, the diameter of the α-crystalline phase of the composition ranges from 3 μm to 25 μm.
  • The diameter D [3, 2] according to the present invention may be measured by static light scattering using a commercial granulometer such as the MasterSizer 3000 machine from Malvern.
  • In particular, the diameter D [3, 2] is measured by the following protocol:
  • diluting the composition according to the present invention to 10%in water. The dilution process can be adjusted according to the viscosity of the composition to be measured by a man skilled in the art;
  • stirring at a speed of 1800 rpm/s; measuring the D [3, 2] of the diluted composition prepared according to the above steps, using MasterSizer 3000;
  • repeating the above steps for 6 times to obtain an average value D [3, 2] .
  • Aqueous phase
  • The composition of the present invention comprises at least one continuous aqueous phase.
  • According to an embodiment, the aqueous phase includes water, as the case may be, in a mixture with water-soluble additives and/or solvents.
  • The aqueous phase may also comprise organic solvents miscible with water (at room temperature -25℃) such as for example monoalcohols having from 2 to 6 carbon atoms such as ethanol, isopropanol; polyols notably having from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and preferentially having from 2 to 6 carbon atoms, such as glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, caprylylglycol, dipropylene glycol, diethylene glycol; glycol ethers (notably having from 3 to 16 carbon atoms) such as mono-, di-or tri-propylene glycol (C1-C4) alkyl ethers, mono-, di-or tri-ethylene glycol (C1-C4) alkyl ethers and mixtures thereof.
  • According to an embodiment, the aqueous phase of the compositions of the present invention comprises a polyol notably glycerol, caprylylglycol or propylene glycol, and a monoalcohol, notably ethanol.
  • The amount of aqueous phase may range, for example, from 70%to 97%by weight, preferably from 75%to 95%by weight relative to the total weight of the composition.
  • According to an embodiment, the amount of water in the compositions according to the present invention ranges from 70%to 97%by weight, preferably from 75%to 95%by weight, relative to the total weight of the composition.
  • Preferably, the compositions of the present invention comprise more than 80%by weight of water relative to the total weight of the composition.
  • The aqueous phase may also contain other additives such as water-soluble active ingredients, preservatives, salts, gelling agents, additional fillers, additional water-soluble or water-dispersible polymers, water-soluble dyes, and so on.
  • Examples of gelling agents are:
  • ○ modified or unmodified carboxyvinyl polymers, such as the products sold under the Carbopol (INCI name: carbomer) and Pemulen (INCI name: Acrylates/C10-30 alkyl acrylate crosspolymer) names by Goodrich;
  • ○ polyacrylamides and polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid which are optionally crosslinked and/or neutralized, such as  the poly (2-acrylamido-2-methylpropanesulphonic acid) sold by Clariant under the name “Hostacerin AMPS” (INCI name: ammonium polyacryloyldimethyl taurate) ; or crosslinked anionic copolymers of acrylamide and of AMPS which are provided in the form of an emulsion, such as those sold under the name of Sepigel 305 (CTFA name: Polyacrylamide/C13-14 Isoparaffin/Laureth-7) , under the name of Simulgel 600 (CTFA name: Acrylamide/Sodium Acryloyldimethyl Taurate Copolymer/Isohexadecane/Polysorbate 80) by SEPPIC or under the name of Simulgel EG (CTFA name: Sodium Acrylate/Sodium Acryloyldimethyl Taurate Copolymer and Isohexadecane and Polysorbate 80) ;
  • ○ acrylate/acrylonitrile copolymers, such as Hypan SS201, sold by Kingston;
  • ○ polysaccharide biopolymers, such as xanthan gum, guar gum, alginates or modified or unmodified celluloses;
  • ○ inorganic compounds, such as smectites or modified or unmodified hectorites, such as the Bentone products sold by Rheox, the Laponite products sold by Southern Clay Products or the product Veegum HS sold by R. T. Vanderbilt;
  • ○ and their mixtures.
  • Use is preferably made, as hydrophilic gelling agent, of optionally crosslinked polymers and copolymers of 2-acrylamido-2-methylpropanesulphonic acid.
  • If exists, the gelling agent can be present in the composition in a content (in dry material) ranging for example from 0.001%to 3%by weight, preferably from 0.01%to 1%by weight, relative to the total weight of the composition.
  • Oily phase
  • A composition according to the present invention comprises at least one dispersed oily phase.
  • According to an embodiment, the oily phase has a refractive index of above 1.43, preferably above 1.50.
  • It has to be noted that the refractive index mentioned above is a final refractive index of the oily phase. There is no limitation on the refractive index of each oil in the oily phase. The oils chosen to be present in the oily phase of the current invention shall reach the condition that the refractive index of the oil phase is of above 1.43, preferably above 1.50.  According to an embodiment, the composition of the present invention, having an α-crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
  • (a) from 1%to 10%by weight of dicaprylyl carbonate, relative to the total weight of the composition;
  • (b) from 3%to 10%by weight of at least one linear or branched saturated alcohols having from 14 to 20 carbon atoms, or any mixture thereof, relative to the total weight of the composition; and
  • (c) from 0.05 to 3%by weight of sodium methyl stearoyl taurate, relative to the total weight of the composition.
  • Process for preparing the composition of the present invention
  • According to one embodiment the composition of the present invention is prepared as follows:
  • - mixing the aqueous phase containing water and (c) at least one anionic surfactant optionally containing active agents;
  • - mixing (a) at least one oil and (b) at least one solid fatty alcohol;
  • - heating separately the mixtures obtained in each of the above steps up to 75-80 ℃ and maintain the temperature with stirring at 250-500 rev /min until homogeneous;
  • - mixing the two mixtures under stirring;
  • - homogenizing the mixture obtained in the previous step at 500~5000 rpm for 10 minutes;
  • - cooling down to room temperature while stirring.
  • Lab Homogenization is preferably performed with a high shear mixer, such as those manufactured by Silverson.
  • Stirring is preferably performed by VMI mixers.
  • Advantageously, the composition of the present invention is a cosmetic composition for caring for and/or making up keratin materials, and may be in form of lotion, toner, cream, or spray.
  • The composition of the present invention is stable over time.
  • “Stable over time” is understood to mean compositions of the present invention which, after storage at all temperatures between 4℃ and 45° for 2 months, do not exhibit any macroscopic change in colour, smell or viscosity, any variation in pH or any variation in microscopic appearance.
  • Method and use
  • The composition of the present invention can be used for a cosmetic process, such as a cosmetic process or method, for making up/caring for the keratin materials, such as the skin, in particular the face and the lips, by being applied to the skin, especially the face.
  • The present invention also relates to a use of the composition according to the present invention, for making up/caring for the skin, especially for the face.
  • The present invention relates to a cosmetic process for caring for and/or making up a keratin material, comprising the application, to the keratin material, of at least one composition of the present invention, wherein the keratin material is preferably the skin, in particular the face.
  • The composition according to the present invention can be used to make the skin anti-finelines during the day. And the composition according to the present invention is easy to spread and penetrate, leaving non-sticky/oily feeling.
  • The examples that follow are aimed at illustrating the compositions and processes according to the present invention, but are not in any way a limitation of the scope of the present invention.
  • EXAMPLES
  • Example 1 Preparation of Invention compositions and comparative compositon
  • Compositions according to the present invention as well as comparative composition were prepared according to the concentration given in table 1.
  • Table 1: Invention compositons 1, 2, and Comparative composition 1
  • Comparative composition 1 comprises less than 3%by weight of solid fatty alcohol.
  • The Invention compositions and comparative composition were prepared following the steps of:
  • 1. melting phase A and phase B, respectively, in a melter at the temperature of 75-80 ℃ with stirring at 1000 rpm /min until a homogeneous phase;
  • 2. adding phase B to phase A, using a mixer at 2300 rpm (silverson) for 10 minutes to obtain a homogenous mixture;
  • 3. stirring the mixture using VMI apparatus at a speed of 500 rpm /min, whiling gradually cooling down the mixture to below 60 ℃ at a speed of 1 ℃ /minute;
  • 4. adding phase C to phase A+B, while stirring using VMI at 800 rpm /min for 10 minutes, leaving the mixture 1 hour for dispersion;
  • 5. diluting phase D with water, and adding the diluted phase D to the mixture obtained above while stirring using VMI above 1000 rpm /min for 10 minutes;
  • Example 2: Evaluation of the Invention compositions and comparative composition α-crystalline phase (α-gel) , the hydrophobic groups of a lamellar liquid crystalline phase are in a molten (liquid) state with a specific sub-lattice structure.
  • To validate the structure of α-crystalline phase (α-gel) , wide-angle X-ray scattering measurement is conducted and α-gel, a sharp peak is observed at 15 nm-1, which corresponds to the diffraction of the sub-lattice.
  • The D [3.2] , haze value, stability and cosmetic property of the compositions according to Invention and the comparative composition were evaluated. The D [3.2] and haze value were evaluated following the method aforementioned.
  • The stability of the compositions according to invention and the comparative composition were evaluated by leaving the compositions at 45 ℃ for 2 months, and observing the compositions using microscope under polarized light.
  • The compositions according to Invention and Comparative composition were given to 10 consumers for application on the facial skin, respectively, and the cosmetic property, such as hydration effect on the skin was scored by the consumers.
  • In particular, when the skin, after application of the compositions, looks homogeneity, without fine lines, it represents a good hydration effect of the product.
  • The results of the evaluation are as follow:
  • Fine skin and daylong not visible fine lines/dehydrated lines are scored according to the following (score from 5 to 1, higher=better)
  • All the above listed compositions are stable over 2 months under the temperature of 45 ℃, with no change both in terms of macro-or micro-appearance.
  • According to the results above, it is obvious that the compositions according to invention both have improved haze (blurring) effects, and such effects are stable over 2 months, under 45 ℃. Besides, the compositions according to the present invention present good hydration effect upon application, comparing to the comparative composition.

Claims (14)

  1. A composition having an α-crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
    (a) at least one oil;
    (b) greater than or equal to 3% by weight of at least one solid fatty alcohol, relative to the total weight of the composition; and
    (c) at least one anionic surfactant of fatty acid amide sulfonate salts,
    wherein the weight ratio of the solid fatty alcohol (b) /the anionic surfactant (c) ranges from 1 to 40,
    and the α-crystalline phase having a surface area moment mean diameter D [3, 2] ranging from 1μm to 35μm.
  2. The composition of claim 1, wherein the oil (a) is selected from hydrocarbon oils, preferably non-volatile hydrocarbon oils, more preferably selected from non-volatile hydrocarbon oils of animal origin, non-volatile hydrocarbon oils of plant origin, linear or branched non-volatile hydrocarbon oils of mineral or synthetic origin, synthetic ethers having from 10 to 40 carbon atoms, oils of formula R1COOR2, in which R1 represents a linear or branched fatty acid residue containing from 1 to 40 carbon atoms, and R2 represents a hydrocarbon-based chain, polyol esters and pentaerythritol esters, esters of diol dimers and diacid dimers, copolymers of a diol dimer and of a diacid dimer and esters thereof, copolymers of polyols and of diacid dimers, and esters thereof, fatty alcohols that are liquid at ambient temperature, C12-C22 fatty acids, dialkyl carbonates, oils of higher molar mass having in particular a molar mass ranging from approximately 400 to approximately 10, 000 g/mol, or a mixture thereof.
  3. The composition of claim 1 or 2, wherein the oil (a) is a dialkyl carbonate of following formula (I) :
    wherein R1 and R2, identical or different, each represents a linear or branched hydrocarbon chain comprising from 3 to 30 carbon atoms; preferably in formula (I) , R1 and R2, which are identical, represent a linear hydrocarbon chain comprising from 3 to 8 carbon atoms;
    more preferably, the dialkyl carbonate is dicaprylyl carbonate.
  4. The composition of any one of the preceding claims 1 to 3, wherein the oil is present in an amount ranging from 0.1% to 15% by weight, preferably ranging from 1% to 10% by weight, relative to the total weight of the composition.
  5. The composition of any one of the preceding claims 1 to 4, wherein the solid fatty alcohol (b) is selected from the fatty alcohol having from 14 to 30 carbon atoms, preferably from 14 to 22 carbon atoms; more preferably selected from the group consisting of myristyl alcohol, cetyl alcohol, palmitoleyl alcohol, stearyl alcohol , arachidyl alcohol, behenyl alcohol, erucyl alcohol, or a mixture thereof; more preferably selected from cetyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, or a mixture thereof.
  6. The composition of any one of the preceding claims 1 to 5, wherein the solid fatty alcohol is present in an amount greater than or equal to 3% by weight, preferably from 3% to 15% by weight, more preferably from 3% to 10% by weight, relative to the total weight of the composition.
  7. The composition of any one of the preceding claims 1 to 6, wherein the surfactant (c) is a amino acid surfactant of formula (II) :
    wherein:
    R1 is a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms atoms,
    R2 is H or a methyl,
    R3 is H, COO-M+, CH2COO-M or COOH,
    n is 0 to 2,
    X is COO-or SO3 -and
    M is independent from each other H, sodium or potassium and a sorbitan surfactant;
    more preferably, the anionic surfactant is a taurate surfactant of formula (III)
    wherein
    R1 is preferably a saturated or unsaturated, straight or branched alkyl chain with 7 to 17 carbon atoms, and more preferably 9 to 13 carbon atoms,
    R2 is H or methyl,
    and M is H, sodium or potassium.
  8. The composition of claim 7, wherein the anionic surfactant is selected from the group consisting of potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium caproyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate, sodium methyl lauroyl taurate, sodium methyl myristoyl taurate, sodium methyl oleoyl taurate, sodium methyl palmitoyl taurate, and sodium methyl stearoyl taurate and mixtures thereof, preferred are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium caproyl methyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate and sodium methyl lauroyl taurate and mixtures thereof, more preferred are potassium cocoyl taurate, potassium methyl cocoyl taurate, sodium cocoyl taurate, sodium lauroyl taurate, sodium methyl cocoyl taurate and sodium methyl lauroyl taurate and mixtures thereof; preferably sodium methyl stearoyl taurate.
  9. The composition of any one of the preceding claims 1 to 8, wherein the anionic surfactant (c) is present in an amount ranging from 0.05% to 3% by weight, and preferably from 0.1% to 1% by weight, relative to the total weight of the composition.
  10. The composition of any one of the preceding claims 1 to 9, wherein the weight ratio of the solid fatty alcohol (b) and the anionic surfactant (c) is from 5 to 35, and more preferably from 15 to 35.
  11. The composition of any one of the preceding claims 1 to 10, wherein the α-crystalline phase has a surface area moment mean diameter D [3, 2] ranging from 1μm to 35 μm, preferably ranges from 3 μm to 25 μm.
  12. The composition of any one of the preceding claims 1 to 11, wherein the oily phase has a refractive index of above 1.43, preferably above 1.50.
  13. A composition having an α-crystalline phase, comprising at least one continuous aqueous phase and at least one dispersed oily phase, and comprising:
    (a) from 1% to 10% by weight of dicaprylyl carbonate, relative to the total weight of the composition;
    (b) from 3% to 10% by weight of at least one linear or branched saturated alcohols having from 14 to 20 carbon atoms, or any mixture thereof, relative to the total weight of the composition; and
    (c) from 0.05 to 3% by weight of sodium methyl stearoyl taurate, relative to the total weight of the composition.
  14. A cosmetic process for caring for and/or making up a keratin material, comprising the application, to the keratin material, of at least one composition of any one of the preceding claims 1 to 13, wherein the keratin material is preferably the skin, in particular the face.
EP16924222.9A 2016-12-23 2016-12-23 Composition having alpha-crystalline phase Active EP3558215B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2016/111643 WO2018112867A1 (en) 2016-12-23 2016-12-23 COMPOSITION HAVING α-CRYSTALLINE PHASE

Publications (4)

Publication Number Publication Date
EP3558215A1 true EP3558215A1 (en) 2019-10-30
EP3558215A4 EP3558215A4 (en) 2020-08-05
EP3558215B1 EP3558215B1 (en) 2024-07-17
EP3558215C0 EP3558215C0 (en) 2024-07-17

Family

ID=62624121

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16924222.9A Active EP3558215B1 (en) 2016-12-23 2016-12-23 Composition having alpha-crystalline phase

Country Status (5)

Country Link
EP (1) EP3558215B1 (en)
JP (1) JP6840850B2 (en)
CN (1) CN110099659B (en)
ES (1) ES2985618T3 (en)
WO (1) WO2018112867A1 (en)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4731109B2 (en) * 2003-10-31 2011-07-20 株式会社 資生堂 Gel composition and cream composition using the same
JP4968774B2 (en) * 2006-08-11 2012-07-04 株式会社 資生堂 Cream composition
JP5554943B2 (en) * 2009-06-03 2014-07-23 花王株式会社 Transparent multilayer liquid cosmetics
US8647649B2 (en) 2009-07-06 2014-02-11 Kao Corporation Emulsified composition
EP2474297A4 (en) * 2009-09-04 2013-03-20 Shiseido Co Ltd Method for producing o/w cream having high viscosity
EP2335681A1 (en) * 2009-12-18 2011-06-22 KPSS-Kao Professional Salon Services GmbH Cleansing composition
JP4767352B1 (en) * 2010-03-17 2011-09-07 株式会社 資生堂 Emulsified composition
CN102028647A (en) * 2010-12-13 2011-04-27 天津盛世永业科技发展有限公司 Composition for relieving legs and preparation method thereof
ES2766877T3 (en) * 2012-12-21 2020-06-15 Oreal Cosmetic composition
WO2015190306A1 (en) * 2014-06-13 2015-12-17 株式会社 資生堂 α-GEL-INTERMEDIATE COMPOSITION, AND PRODUCTION METHOD FOR α-GEL-CONTAINING O/W EMULSION COSMETIC USING SAID COMPOSITION
EP3269354B1 (en) * 2015-03-10 2020-01-01 The Nisshin OilliO Group, Ltd. Water-based cosmetic
CN108697589B (en) * 2015-10-30 2022-03-18 欧莱雅 Composition with alpha crystalline phase
CN105902428A (en) * 2016-05-09 2016-08-31 广州嘉工生物科技有限公司 Quintuple-treatment ginseng cream and preparation method thereof

Also Published As

Publication number Publication date
JP6840850B2 (en) 2021-03-10
ES2985618T3 (en) 2024-11-06
EP3558215B1 (en) 2024-07-17
EP3558215A4 (en) 2020-08-05
EP3558215C0 (en) 2024-07-17
WO2018112867A1 (en) 2018-06-28
JP2019535768A (en) 2019-12-12
CN110099659A (en) 2019-08-06
CN110099659B (en) 2022-04-26

Similar Documents

Publication Publication Date Title
US11382857B2 (en) Composition comprising a fatty phase, a lipophilic polymer and a volatile hydrocarbon-based oil
JP6057461B2 (en) Alpha gel structure and cosmetic or skin external preparation containing the same
WO2017070940A1 (en) COMPOSITION HAVING A α-CRYSTALLINE PHASE
EP3915642A1 (en) Novel composite body and emulsion composition
KR102831807B1 (en) Water-in-oil emulsion type cosmetic composition
RU2632712C2 (en) Solid cosmetic composition for application of makeup and/or care
US20240156705A1 (en) Cosmetic composition comprising at least one polar oil, a polyol and at least one hydrophilic active agent
EP3558215B1 (en) Composition having alpha-crystalline phase
CN113631142A (en) Oil-in-water nanoemulsion containing nonionic surfactant and ionic surfactant
US11642293B2 (en) Composition for caring for skin, method and use thereof
KR102777610B1 (en) Oil-in-water type cosmetic composition having excellent formulation stability
EP3466402A1 (en) Oily gelatinous composition and cosmetic or topical agent containing same
CN114073648A (en) Cosmetic composition comprising natural polymers
WO2025132572A1 (en) Cosmetic composition comprising an oil, an alkanol, a polyol, azelaic acid and a low content of water
JP7800831B2 (en) Hydroquinone-containing topical skin preparation and method for producing said hydroquinone-containing topical skin preparation
WO2019205047A1 (en) Two-phase composition for topical application
JP2018537463A (en) Composition having color conversion upon application
WO2024248025A1 (en) Water-in-oil type emulsifier and water-in-oil type emulsion composition
WO2022021329A1 (en) Composition for caring for the keratin materials and a method to use thereof
WO2025133193A1 (en) Cosmetic composition of the oil-in-water emulsion type, having a powdery perception
WO2011074127A1 (en) Composition with enhanced hydration ability

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20190423

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20200703

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/06 20060101AFI20200629BHEP

Ipc: A61K 8/34 20060101ALI20200629BHEP

Ipc: A61K 8/37 20060101ALI20200629BHEP

Ipc: A61K 8/46 20060101ALI20200629BHEP

Ipc: A61Q 19/00 20060101ALI20200629BHEP

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SONG, JI

Owner name: L'OREAL

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SONG, JI

Owner name: L'OREAL

Owner name: WENG, XIAOMIN

Owner name: LU, HAIQUAN

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20210923

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: LU, HAIQUAN

Owner name: WENG, XIAOMIN

Owner name: SONG, JI

Owner name: L'OREAL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0008060000

Ipc: A61K0008460000

Ref country code: DE

Ref legal event code: R079

Ref document number: 602016088494

Country of ref document: DE

Free format text: PREVIOUS MAIN CLASS: A61K0008060000

Ipc: A61K0008460000

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 8/42 20060101ALI20240130BHEP

Ipc: A61K 8/33 20060101ALI20240130BHEP

Ipc: A61K 8/34 20060101ALI20240130BHEP

Ipc: A61Q 19/00 20060101ALI20240130BHEP

Ipc: A61K 8/46 20060101AFI20240130BHEP

INTG Intention to grant announced

Effective date: 20240219

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602016088494

Country of ref document: DE

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

U01 Request for unitary effect filed

Effective date: 20240731

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20240820

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2985618

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20241106

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 9

Effective date: 20241107

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241018

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241117

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241017

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241017

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241017

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241117

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20241018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20250422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20241231

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20241223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20240717

U20 Renewal fee for the european patent with unitary effect paid

Year of fee payment: 10

Effective date: 20251110

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20251001

Year of fee payment: 10

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20260119

Year of fee payment: 10